Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta-Lactamases: protein evolution in real time

J Petrosino1, C Cantu, T Palzkill

  • 1Dept of Microbiology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.

Trends in Microbiology
|September 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognosis of patients with severe cerebral venous thrombosis treated with decompressive craniectomy.

Neurologia·2023
Same author

Anorexia in Medicare Fee-for-Service Beneficiaries: A Claims-Based Analysis of Epidemiology and Mortality.

The journal of nutrition, health & aging·2023
Same author

Prognosis of patients with severe cerebral venous thrombosis treated with decompressive craniectomy.

Neurologia·2021
Same author

Simulating the activation, contraction and movement of skeletal muscles using the bidomain model.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2017
Same author

Aseptic cerebral venous thrombosis: Proposed prognostic scale.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Novel compliant actuator for wearable robotics applications.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2013
Same journal

Structural inequalities in global antimicrobial resistance governance.

Trends in microbiology·2026
Same journal

Environmental microbes as modulators of plant volatile landscapes: Implications for plant-insect chemical communication.

Trends in microbiology·2026
Same journal

Beyond AMGs: Phage-encoded transcription and sigma factors as understudied virocell reprogramming tools.

Trends in microbiology·2026
Same journal

Cronobacter spp.

Trends in microbiology·2026
Same journal

Anaerobic lignin deconstruction: A game changer for lignocellulosic biorefineries.

Trends in microbiology·2026
Same journal

Critical role of the inflammatory rheostat in influenza-associated pulmonary aspergillosis.

Trends in microbiology·2026
See all related articles

Bacteria are rapidly evolving resistance to beta-lactam antibiotics through gene mutation or acquisition. New variants of TEM and SHV beta-lactamases demonstrate altered substrate specificity, contributing to this alarming trend.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • The rapid increase in antibiotic resistance poses a significant global health threat.
  • Beta-lactam antibiotics are widely used but increasingly ineffective due to bacterial resistance mechanisms.

Purpose of the Study:

  • To investigate the mechanisms of bacterial resistance to beta-lactam antibiotics.
  • To highlight the evolution of beta-lactamase enzymes, such as TEM and SHV, as a key factor in resistance.

Main Methods:

  • Analysis of bacterial genetic mechanisms for acquiring drug resistance.
  • Studying the evolution of beta-lactamase genes and their variants.

Main Results:

  • Bacteria acquire resistance via gene mutation or horizontal gene transfer.

Related Experiment Videos

  • Evolution of TEM and SHV beta-lactamases leads to altered substrate specificity, enhancing resistance.

    • Conclusions:

    • Bacterial resistance to beta-lactam antibiotics is driven by genetic evolution.
    • Emerging beta-lactamase variants represent a critical challenge in antibiotic therapy.